SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-24-000386
Filing Date
2024-03-12
Accepted
2024-03-12 16:55:02
Documents
14
Period of Report
2024-03-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 24556
  Complete submission text file 0000950157-24-000386.txt   163034

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amam-20240308.xsd EX-101.SCH 3857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20240308_lab.xml EX-101.LAB 23291
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20240308_pre.xml EX-101.PRE 16547
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4230
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 24743015
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)